Akili (NASDAQ:AKLI) stock is rocketing higher on Tuesday after the digital medicine company provided investors with a positive corporate update. According to this update, Shionogi has canceled and forgiven $5 million in debt that Akili owed it. The company has also agreed to make payments for Akili’s SDT-001. That includes a$10.5 million upfront payment to cancel future royalty payments and milestone payments. To go along with that, Akili is still eligible for up to $4.5 million in payments from Shionogi f ...